~~<i id='812D16C666'><strike id='812D16C666'><tt id='812D16C666'><pre id='812D16C666'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

focus

author：knowledge 2025-10-02 17:21:09 - browse：2

AP/Richard Drew

Johnson & Johnson said Monday that it would purchase Ambrx Biopharma for nearly $2 billion, picking up a company specializing in targeted chemotherapy treatments — one of the hottest areas of cancer drug development.

The deal, disclosed as the biopharma field marked the first day of the annual J.P. Morgan Healthcare Conference, extends a recent spate of pharma acquisitions, contributing to hopes that 2024 could be a better year for the industry.

Under the agreement, J&J will pay $28 per share in cash for Ambrx, roughly a 100% premium to the latter’s recent trading price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： IVF, abortion rights issues kick off Biden’s State of the Union

Wikipedia

entertainment

focus

VenturecapitalistAlexisBorisyVanessaLeroyforSTATEQRxisdone,soldforitscash.Theonce-buzzy butnowdorman

WSS

IVF, abortion rights issues kick off Biden’s State of the Union

Novo Nordisk obesity pill bests Wegovy in early trial

National panel will explore requiring free Covid tests

Precocious puberty in girls comes with mental health risks

Mitch McConnell episode has important public health takeaway

What the airline industry can learn from medicine

Wikipedia

focus

Wikipedia

Hollywood unions extend contract negotiations for actors

Just how do doctors, lawmakers, and the public define abortion?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Just how do doctors, lawmakers, and the public define abortion?

United colonoscopy coverage change 'may cost lives,' doctors say

5 important ways Henrietta Lacks changed medical science

Drug repurposing or repositioning? The language matters

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

With psoriasis trial ahead, Alumis raises $259 million

entertainment

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

NEJM study link tiny plastics in blood vessels to heart problems

Sen. Paul opposes bill to ban Chinese biotechs

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Scientists inch closer to single

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

entertainment

focus

focus

focus